Clinical Trials Directory

Trials / Unknown

UnknownNCT03638414

ePainQ - Feasibility Study

ePainQ - a Web-based Pain Self-management System for Patients Undergoing Surgery for Breast Cancer: Feasibility Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
The Leeds Teaching Hospitals NHS Trust · Academic / Other
Sex
Female
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This is a feasibility study of a web-based pain self-management system aimed at providing support for acute postoperative pain and enhancing patient care. The ePainQ symptom questionnaire provides patients with immediate graded advice dependent on severity of issues reported. Information about self-managing these issues are provided via instructions in ePainQ with hyperlinks to more detailed advice on the ePainQ website. Patients log on daily postoperatively to complete the symptom questionnaire. Women with invasive/non-invasive breast carcinoma due to be treated by surgery with curative intent will be approached to take part in this study. We will invite consecutive eligible patients, consenting as many willing patients as possible within a fixed 12 month recruitment period. There are 2 arms to the study: intervention -using ePainQ intervention \& standard care and a cohort (control) arm, which will be standard care only. Primary aim: To test the feasibility of a web-based pain self-management system for breast cancer patients undergoing surgery Secondary aims: 1. a) Examine preliminary effectiveness of the system (impact on outcome measures, pain etc.) b) Explore the potential associations between breast density, post-surgical scarring and pain and outcomes 2. To explore staff use and perceived usefulness of ePainQ in clinical consultations.

Conditions

Interventions

TypeNameDescription
OTHERePainQ questionnaireThis is a questionnaire which will be given to the intervention group about their perceptions of treatment. It will be online.

Timeline

Start date
2018-08-06
Primary completion
2020-03-30
Completion
2020-03-30
First posted
2018-08-20
Last updated
2018-08-20

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03638414. Inclusion in this directory is not an endorsement.